UNSW GSOE9510 I declare that this assessment item is my own work, except where acknowledged, and has never been submitted for academic credit elsewhere. I acknowledge that the assessor of this item may, for the purpose of assessing this item, (i) reproduce this assessment item and provide a copy to another member of the University, and/or (ii) communicate a copy of this assessment item to a plagiarism checking service (which may then retain a copy of the assessment item on its database for the purpose of future plagiarism checking). I certify that I have read and understood the University Rules about Student Academic Miscon- duct. Signature: Name: Taha Mansoor Rizvi Date:27-Jan-2021 Student ID: z5318372 1 (a) Recent dilemma of COVID has pushed multiple research groups around the world to develop vaccine on a fast track basis against the norms of standard vaccine development. University of Queensland/CSL vaccine was one of the joint ventures from Australia entered research of vaccine.1 (b) Development of COVD vaccine at University of Queensland was based on Molecular Clamp technology which acted as the platform approach to generate vaccine against a range of human and animal viruses showing promising results within laboratory targeting viruses such as Ebola, influenza and MERS coronavirus. All human beings are considered as stakeholder for this development and holds equal right to get to know about the development of vaccine and possible implications associated with it. Vaccine which was being developed by University of Queensland were showing promising result during phase-1 trial, but unexpected observation related to interference with HIV tests were made on few participants during the course of trials. There is no possibility of vaccine causing a HIV infection which was verified by carrying out HIV virus tests. This abnormal finding during a trail was unavoidable considering the overall progress of the research and further research could have resulted in agitation within common public. Research joint venture decided to put a hold phase-2 trial of vaccine and made a public announcement about it with reasons. (c) All participants involved in vaccine trial were counselled on each possible outcome and they were also updated on unforeseen observation related to identification of incorrect HIV virus. Considering the outcome of the phase-1 trial, decision was made by University of Queensland/CSL vaccine to abandon the further trial of vaccine and all participants including general public were made aware of it. (d) Representative of research group proven themselves ethical by carrying out the transparent trial of vaccine by not only keeping trial participants up to date on the progress during trial but also communicate the same to all stakeholders.2 1 2 https://stories.uq.edu.au/research/impact/2020/uq-responds-to-coronavirus-outbreak/index.html https://www.uq.edu.au/news/article/2020/12/update-uq-covid-19-vaccine 2
